Verastem (VSTM) Capital Expenditures (QoQ) (2011 - 2024)
Verastem (VSTM) Capital Expenditures (QoQ) (2011 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Verastem |
407.42 Mn |
225.74 Mn |
15.90 Mn |
| Date | Value |
|---|
| Jun 30, 2024 |
-66.67% |
| Sep 30, 2020 |
3,114.29% |
| Jun 30, 2020 |
-153.85% |
| Dec 31, 2018 |
-63.32% |
| Sep 30, 2018 |
68.71% |
| Jun 30, 2018 |
316.67% |
| Dec 31, 2015 |
-12.50% |
| Mar 31, 2015 |
111.76% |
| Dec 31, 2014 |
-214.90% |
| Sep 30, 2014 |
260.70% |
| Jun 30, 2014 |
3,920.00% |
| Mar 31, 2014 |
-50.00% |
| Dec 31, 2013 |
300.00% |
| Dec 31, 2012 |
-107.14% |
| Sep 30, 2012 |
316.22% |
| Jun 30, 2012 |
-71.54% |
| Mar 31, 2012 |
319.35% |
| Dec 31, 2011 |
-91.60% |
